Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in BMJ

Retrieve available abstracts of 49 articles:
HTML format

Single Articles

    June 2021
  1. KOVACS MJ, Wells PS, Anderson DR, Lazo-Langner A, et al
    Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial.
    BMJ. 2021;373:n1205.
    PubMed     Abstract available

    May 2021
  2. PERRY M, Kemmis Betty S, Downes N, Andrews N, et al
    Atrial fibrillation: diagnosis and management-summary of NICE guidance.
    BMJ. 2021;373:n1150.

  3. KIM D, Yang PS, You SC, Sung JH, et al
    Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study.
    BMJ. 2021;373:n991.
    PubMed     Abstract available

    April 2021
  4. PONAMGI SP, Siontis KC, Rushlow DR, Graff-Radford J, et al
    Screening and management of atrial fibrillation in primary care.
    BMJ. 2021;373:n379.
    PubMed     Abstract available

    September 2020
  5. UITTENBOGAART SB, Verbiest-van Gurp N, Lucassen WAM, Winkens B, et al
    Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial.
    BMJ. 2020;370:m3208.
    PubMed     Abstract available

    August 2020
  6. VINTER N, Huang Q, Fenger-Gron M, Frost L, et al
    Trends in excess mortality associated with atrial fibrillation over 45 years (Framingham Heart Study): community based cohort study.
    BMJ. 2020;370:m2724.
    PubMed     Abstract available

    February 2020
  7. KAPELIOS CJ, Bonou M, Barbetseas J, Makrilakis K, et al
    An unexpected finding on a chest radiograph.
    BMJ. 2020;368:m426.

    January 2020
  8. MOHANAN NAIR KK, Namboodiri N, Valaparambil A
    Syncope in a young woman.
    BMJ. 2020;368:l6877.

    NICE recommends implantable monitor to identify atrial fibrillation after stroke.
    BMJ. 2020;368:m133.

    November 2019
  10. BHATTI A, Oakeshott P, Dhinoja M, Grapsa J, et al
    Ablation therapy in atrial fibrillation.
    BMJ. 2019;367:l6428.

    October 2019
  11. MIRZAZADEH M, Alijani E, Fani M, Jamili S, et al
    A 44 year old woman with episodic sweating and hypertension.
    BMJ. 2019;367:l5879.

    July 2019
  12. MAHASE E
    Atrial fibrillation groups lobby patients to overturn screening committee decision.
    BMJ. 2019;366:l4612.

    June 2019
  13. STEELE R, Marshall J, Mackie A
    Screening for atrial fibrillation: waiting for randomised trial data.
    BMJ. 2019;365:l2383.

    April 2019
  14. BERGE T
    Wilson and Jungner would not approve of screening for atrial fibrillation.
    BMJ. 2019;365:l1416.

    March 2019
    Screening for atrial fibrillation: one size does not fit all.
    BMJ. 2019;364:l1396.

  16. MAYOR S
    Catheter ablation for atrial fibrillation no better than drug therapy for reducing death or disabling stroke, trial finds.
    BMJ. 2019;364:l1254.

    February 2019
  17. IZAWA J, Komukai S, Gibo K, Okubo M, et al
    Pre-hospital advanced airway management for adults with out-of-hospital cardiac arrest: nationwide cohort study.
    BMJ. 2019;364:l430.
    PubMed     Abstract available

  18. LOWN M, Moran P
    Should we screen for atrial fibrillation?
    BMJ. 2019;364:l43.

    October 2018
  19. ABRAHAM G, Ghazanfar MA, Bajpai A
    An unusual cause of shortness of breath and palpitations.
    BMJ. 2018;363:k3883.

    Newer technologies for detection of atrial fibrillation.
    BMJ. 2018;363:k3946.
    PubMed     Abstract available

  21. MARRIOTT C, George C
    New onset atrial fibrillation, prominent chest wall veins, and dyspnoea.
    BMJ. 2018;363:k3779.

    July 2018
  22. VINOGRADOVA Y, Coupland C, Hill T, Hippisley-Cox J, et al
    Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care.
    BMJ. 2018;362:k2505.
    PubMed     Abstract available

    May 2018

  23. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
    BMJ. 2018;361:k2295.

  24. SILVERWOOD RJ, Forbes HJ, Abuabara K, Ascott A, et al
    Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study.
    BMJ. 2018;361:k1786.
    PubMed     Abstract available

  25. ADDERLEY NJ, Nirantharakumar K, Marshall T
    Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies.
    BMJ. 2018;361:k1717.
    PubMed     Abstract available

  26. GRECH ED, Zwart B
    A man with chest pain and a broad QRS complex tachycardia.
    BMJ. 2018;361:k1191.

    April 2018
  27. STAERK L, Wang B, Preis SR, Larson MG, et al
    Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study.
    BMJ. 2018;361:k1453.
    PubMed     Abstract available

    March 2018
  28. HONARBAKHSH S, Hunter L, Chow A, Hunter RJ, et al
    Bradyarrhythmias and pacemakers.
    BMJ. 2018;360:k642.

    February 2018
  29. KUMAR S, de Lusignan S, McGovern A, Correa A, et al
    Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care.
    BMJ. 2018;360:k342.
    PubMed     Abstract available

    January 2018
  30. ADELBORG K, Szepligeti SK, Holland-Bill L, Ehrenstein V, et al
    Migraine and risk of cardiovascular diseases: Danish population based matched cohort study.
    BMJ. 2018;360:k96.
    PubMed     Abstract available

  31. HUNT BJ, Levi M
    Urgent reversal of vitamin K antagonists.
    BMJ. 2018;360:j5424.

    December 2017

  32. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
    BMJ. 2017;359:j5631.

    November 2017
  33. LOPEZ-LOPEZ JA, Sterne JAC, Thom HHZ, Higgins JPT, et al
    Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
    BMJ. 2017;359:j5058.
    PubMed     Abstract available

  34. BALL J
    Which anticoagulant for stroke prevention in atrial fibrillation?
    BMJ. 2017;359:j5399.

    A young man with palpitations and pre-syncope.
    BMJ. 2017;359:j4846.

    October 2017
  36. MAYOR S
    Men develop atrial fibrillation 10 years earlier than women, finds study.
    BMJ. 2017;359:j4802.

  37. FLOYD CN, Ferro A
    Indications for anticoagulant and antiplatelet combined therapy.
    BMJ. 2017;359:j3782.

    September 2017
    Over 15% of atrial fibrillation patients are not prescribed any antithrombotic agent for stroke prevention by GPs.
    BMJ. 2017;358:j4467.

    July 2017
  39. ABI KHALIL C, Haddad F, Al Suwaidi J
    Investigating palpitations: the role of Holter monitoring and loop recorders.
    BMJ. 2017;358:j3123.

    June 2017
  40. DAVIES RH, Thomas DE
    Heart rhythm conundrum.
    BMJ. 2017;357:j2215.

    May 2017
    A case of palpitation and pre-syncope.
    BMJ. 2017;357:j2343.

  42. HIPPISLEY-COX J, Coupland C, Brindle P
    Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
    BMJ. 2017;357:j2099.
    PubMed     Abstract available

  43. MILLER EO, Krishnamoorthy VK, Ling FSK, Chaturvedi A, et al
    A man with chest pain and acute ST elevations on electrocardiogram.
    BMJ. 2017;357:j2198.

  44. YI Z, Huang YS, Wang L, Zhao YT, et al
    A man with chest tightness and burning limbs.
    BMJ. 2017;357:j1979.

    November 2016
  45. MAYOR S
    More than half of stroke patients were not given preventive drugs, study finds.
    BMJ. 2016;355:i6105.

  46. SUKKAR L, Hong D, Wong MG, Badve SV, et al
    Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis.
    BMJ. 2016;355:i5599.
    PubMed     Abstract available

    October 2016
  47. MOORE TJ
    Optimal dosing of rivaroxaban is undefined.
    BMJ. 2016;355:i5549.

    Bleeding risk higher with rivaroxaban than dabigatran for stroke prevention, head-to-head trial shows.
    BMJ. 2016;355:i5362.

    August 2016
  49. WISE J
    Most patients taking warfarin do not maintain stable INR values.
    BMJ. 2016;354:i4402.

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.